Asset Details
Do you wish to reserve the book?
Antiviral Development for the Polio Endgame: Current Progress and Future Directions
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Antiviral Development for the Polio Endgame: Current Progress and Future Directions
Do you wish to request the book?
Antiviral Development for the Polio Endgame: Current Progress and Future Directions
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Antiviral Development for the Polio Endgame: Current Progress and Future Directions
2024
Overview
As the world is approaching the eradication of wild poliovirus serotype 1, the last of the three wild types, the question of how to maintain a polio-free world becomes imminent. To mitigate the risk of sporadic vaccine-associated paralytic polio (VAPP) caused by oral polio vaccines (OPVs) that are routinely used in global immunization programs, the Polio Antivirals Initiative (PAI) was established in 2006. The primary goal of the PAI is to facilitate the discovery and development of antiviral drugs to stop the excretion of immunodeficiency-associated vaccine-derived poliovirus (iVDPV) in B cell-deficient individuals. This review summarizes the major progress that has been made in the development of safe and effective poliovirus antivirals and highlights the candidates that have shown promising results in vitro, in vivo, and in clinical trials.
Publisher
MDPI AG,MDPI
Subject
/ Antiviral Agents - pharmacology
/ Antiviral Agents - therapeutic use
/ Food contamination & poisoning
/ Genomes
/ Humans
/ immunodeficiency-associated vaccine-derived poliovirus
/ LDCs
/ Poliomyelitis - epidemiology
/ Poliomyelitis - prevention & control
/ Proteins
/ Review
/ small molecule-based antiviral drug
/ Vaccines
/ Viruses
